Radiation Oncology

Peng Zhenwei

Associate professor

Overview

Clinical Interests：

Liver cancer, pancreatic cancer, colon cancer

?

Medical Education：

Ph.D.

?

Work Experiences：

Beth Israel Deaconess Medical Center, Harvard

The First Affiliated Hospital, Sun Yat-sen University

?

Visits
Sunday: Closed
Monday: Closed
Tuesday: 8:00-12:00 939
Wednesday: Closed
Thursday: Closed
Friday: Closed
Saturday: Closed
Address

Biography

1. Peng ZW, Chen SL, Wei MC, et al. Sorafenib with or without Transarterial Chemoembolization plus Radiofrequency Ablation for Advanced Recurrent Hepatocellular Carcinoma. Radiology, in press. IF: 7.296

2. Peng ZW, Wei MC, Chen SL, et al. Combined Transcatheter Arterial Chemoembolization and Radiofrequency Ablation versus Hepatectomy for Recurrent Hepatocellular carcinoma after Initial Surgery: A Propensity Score Matching study. Euro Radiol, in press. IF: 3.967

3. Chen SL, PengZW, Xiao H, et al. Combined Radiofrequency Ablation and Ethanol Injection Versus Repeat Hepatectomy for Elderly Patients with Recurrent Hepatocellular Carcinoma after Initial Hepatic Surgery. Int J Hyperthermia. 2017. Co-first author. IF: 3.262

4. Peng ZW, Rothweiler S, Wei GY, et al. The ectonucleotidase ENTPD1/CD39 limits biliary injury and fibrosis in mouse models of sclerosing cholangitis. Hepatol commun. 2017;1:957-972.

5. Peng ZW, Ikenaga N, Liu SB, et al. Integrin αvβ6 critically regulates hepatic progenitor cell function and promotes ductular reaction, fibrosis, and tumorigenesis. Hepatology; 2016;63:217-32. IF: 13.246

6. Xu L, Peng ZW, Chen MS, et al.?Prognostic Nomogram for Patients with Unresectable Hepatocellular Carcinoma After Transcatheter Arterial Chemoembolization.?J Hepatol 2015;63:122-30 Co-first author. IF: 12.486